OR9I3P

Across TCGA pan-cancer cohorts, OR9I3P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR9I3P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR9I3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR9I3P expression acts as an unfavorable survival marker, although some lineages such as KIRP and KIRC show a favorable association.

LIHC, BLCA, and READ are the cancer types where OR9I3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.367	0.790	<.001	48	view →
BLCA	OS	Tertile	IV	0.132	0.604	<.001	42	view →
READ	DFS	Tertile	All	0.235	0.703	.003	36	view →
KIRP	OS	Tertile	III,IV	1.000	0.334	.008	24	view →
KIRC	DFS	Tertile	All	0.907	0.854	.019	20	view →
UVM	DFS	Tertile	III,IV	0.079	0.674	.020	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
COAD	DFS	Tertile	III,IV	0.252	0.669	.026	18	view →
CESC	DFS	Tertile	III,IV	0.240	0.726	.015	18	view →
THCA	DFS	Tertile	IV	0.146	0.844	.007	9	view →
PAAD	OS	Tertile	All	0.759	0.448	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR9I3P–LIHC (OS)

Open the LIHC breakdown →